Search
for
Sort by
Research 151–180 of 1000+
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Development of Autoimmune Hair Loss Disease Alopecia Areata Is Associated with Cardiac Dysfunction in C3H/HeJ Mice
- The potential involvement of cholinergic system in finasteride induced cognitive dysfunction
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Evaluation of dry eye and Meibomian gland dysfunction in female androgenetic alopecia patients
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Testosterone therapy for sexual dysfunction in postmenopausal women
- The eye and the skin in endocrine metabolic diseases
- Adrenal causes of endocrine hypertension in childhood or adolescence
- Androgenic modulation of arterial baroreceptor dysfunction and neuroinflammation in endotoxic male rats
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Impact of Hormones on Female Sexual Function and Dysfunction
- Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Association Between Androgenetic Alopecia Severity and Sexual Dysfunction in Male and Female Patients Attending a Dermatology Clinic: An Exploratory Cross-Sectional Study
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding
- A descriptive study of alopecia patterns and their relation to thyroid dysfunction